Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01481272
What this trial is testing

Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Polish Lymphoma Research Group 77
Not applicableWithdrawnNCT02225795
What this trial is testing

Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.

Who this might be right for
Crohn's Disease
TriStar Health
Not applicableLooking for participantsNCT06111612
What this trial is testing

Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic Leukemia+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Large-scale testing (Phase 3)Looking for participantsNCT07678229
What this trial is testing

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Rong Tao 150
Not applicableUnknownNCT03605953
What this trial is testing

Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell (HSC) Transplantation
Central Hospital, Nancy, France 134
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Testing effectiveness (Phase 2)Study completedNCT00002509
What this trial is testing

High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer

Who this might be right for
Breast Cancer
Temple University
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Early research (Phase 1)UnknownNCT05005299
What this trial is testing

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2+3 more
Melbourne Health 18
Early research (Phase 1)Study completedNCT00606437
What this trial is testing

Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants

Who this might be right for
LymphomaMyelomaLeukemia+4 more
Duke University 40
Testing effectiveness (Phase 2)Study completedNCT00306111
What this trial is testing

Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
University Hospital Tuebingen 14
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Early research (Phase 1)UnknownNCT04706312
What this trial is testing

Transplantation of hAMSCs for Woman With DOR

Who this might be right for
Diminished Ovarian Response
The First Affiliated Hospital with Nanjing Medical University 12
Not applicableStudy completedNCT04808167
What this trial is testing

Remote Ischemic Conditioning in HSCT

Who this might be right for
Hematopoietic Stem Cell Transplantations
Children's Hospital Medical Center, Cincinnati 17
Testing effectiveness (Phase 2)Ended earlyNCT03615144
What this trial is testing

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

Who this might be right for
Non-Malignant Hematologic Disorders
Memorial Sloan Kettering Cancer Center 1
Early research (Phase 1)Study completedNCT00641030
What this trial is testing

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 20
Not applicableActive Not RecruitingNCT05271630
What this trial is testing

Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 69
Next Page